Pulmatrix (NASDAQ:PULM) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of Pulmatrix (NASDAQ:PULM – Get Free Report) in a research note issued to investors on Tuesday. The brokerage set a “sell” rating on the biotechnology company’s stock. Pulmatrix Stock Performance NASDAQ:PULM opened at $6.13 on Tuesday. Pulmatrix has a 1 year low of $1.72 and a 1 year high of […]

Leave a Reply

Your email address will not be published.

Previous post Spoiler alert: Here’s how Eagan native Eva Erickson fared on ‘Survivor’ finale
Next post Titan Pharmaceuticals (NASDAQ:TTNP) Now Covered by StockNews.com